Research Progress on Anthracycline in the Treatment of HER2 Positive Breast Cancer
The application of anthracyclic drugs is one of the cornerstones of breast cancer treat-ment.However,the status of anthracycline drugs in the new adjuvant and adjuvant treatment of human epidermal growth factor receptor 2(HER2)positive breast cancer is facing a challenge at present,due to its cardiac toxicity and the development of new anti-HER2 drugs.This paper dis-cusses the"fate"of anthracycline drugs in new adjuvant and adjuvant treatment of HER2 positive breast cancer,bases on the recent research evidence and evidence-based medicine.
breast cancerHER2anthracyclineneoadjuvant therapyadjuvant therapy
万方数据
维普
